Sleep modulates cannabinoid receptor 1 expression in the pons of rats

Neuroscience

Volumn 117, Issue 1, 2003, Pages 197-201

  Martinez Vargas M ^a   Murillo Rodriguez E ^a   Gonzalez Rivera R ^a   Landa, A ^a   Mendez Diaz M ^a   Prospero Garcia O ^a   Navarro, L ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

CB1; Circadian rhythm; Pons; REM sleep; Sleep deprivation

Indexed keywords

CANNABINOID 1 RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CIRCADIAN RHYTHM; CONTROLLED STUDY; GENE EXPRESSION REGULATION; LIGHT DARK CYCLE; MALE; NONHUMAN; PONS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEEP; SLEEP DEPRIVATION; STRESS; WESTERN BLOTTING;

EID: 0345505329     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00820-5     Document Type: Article

References (28)

1. Aceves C., Pineda O., Ramírez C.I., Navarro L., Valverde R.C. Mammary Type I Deiodinase (M-D1) is dependent on the suckling stimulus. Differential role of norepinephrine and prolactin. Endocrinol. 140:1999;2948-2953.
2. Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol. 58:1999;315-348.
3. Axelrod J., Felder C.C. Cannabinoid receptors and their endogenous agonist, anandamide. Neurochem Res. 23:1998;575-581.
4. Basile A.S., Hanus L., Mendelson W.B. Characterization of the hypnotic properties of oleamide. Neuroreport. 10:1999;947-951.
5. Bisogno T., Berendero F., Ambrosino G., Cebeira M., Ramos J.A., Fernández-Ruiz J.J., DiMarzo V. Brain Regional Distribution of Endocannabinoids implications for their biosynthesis and biological function. Biochem Biphys Res Commun. 256:1999;377-380.
6. Boring D.L., Berlung D.A., Howlett A.C. Cerebrodiene, arachidonyl-ethanolamide, and hybrid strutures potential for interaction with brain cannabinoid receptors. Prostaglandins Leukot Essent Fatty Acids. 55:1996;207-210.
7. Bruinink A., Lichtensteiger W., Schlumpf M. Ontogeny of diurnal rhythms of central dopamine, serotonine and spirodecanone bindings sites and of motor activity in the rat. Life Sciences. 33:1983;31-38.
8. Burbach J.P., Liu B., Voorhuis T.A., Van Tol H.H. Diurnal variation in vasopressin and oxytocin messenger RNAs in hypothalamic nuclei of the rat. Brain Res. 464:1988;157-160.
9. Cravatt B.F., Prospero-Garcia O., Siuzdak G., Gilula N.B., Henriksen S.J., Boger D.L., Lerner R.A. Chemical characterization of a family of brain lipids that induce sleep. Science. 268:1995;1506-1509.
10. Glass M., Dragunow M., Faull R.L. Cannabinoid receptors in the human brain a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 77:1997;299-318.
11. Greco M.A., McCarley R.W., Shiromani P.J. Choline acetyltransferase expression during periods of behavioral activity and across natural sleep-wake states in the basal forebrain. Neuroscience. 93:1999;1369-1374.
12. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
13. Ledoux L., Sastre J.P., Buda C., Luppi P.H., Jouvet M. Alterations in c-fos expression after different experimental procedures of sleep deprivation in the cat. Brain Res. 735:1996;108-118.
14. Mechoulam R., Fride E., Hanus L., Sheskin T., Bisogno T., Di Marzo V., Bayewitch M., Vogel Z. Anandamide may mediate sleep induction. Nature. 389:1997;25-26.
15. Mechoulam R., Fride E., Di Marzo V. Endocannabinoids. Eur J Pharmacol. 359:1998;1-18.
16. Mechoulam R., Hanus L., Fride E. Towards cannabinoid drugs- revisited. Progr Med Chem. 35:1998;199-243.
17. Murillo-Rodríguez E., Sánchez-Alavez M., Navarro L., Martínez-González D., Drucker-Colín R., Prospéro-García O. Anandamide modulates sleep and memory in rats. Brain Res. 812:1998;270-274.
18. Murillo-Rodríguez E., Cabeza R., Méndez-Díaz M., Navarro L., Prospéro-García O. Anadamide-induced sleep is blocked by SR141716A, a CB1 receptor anatagonist and by U73122, a phospholipase C inhibitor. NeuroReport. 12:2001;2131-2136.
19. Murillo-Rodríguez E, Giuffrida A, Desnaurd F, Prospero-García O, Piomelli D (2001b) Diurnal variations of endogenous cannabinoid in CSF and brain of the rat. 33rd Annual Meeting of the Society for Neurosciences, San Diego, California. Abs 805.2.
20. Naber D., Wirz-Justice A., Kafka M.S., Tobler I., Borbely A.A. Seasonal variations in the endogenous rhythm of dopamine receptor binding in rat striatum. Biol Psychiatry. 16:1981;831-835.
21. Petit D.A.D., Harrison M.P., Olson J.M., Spencer R.F., Cabral G.A. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Nerosci Res. 51:1998;391-402.
22. Pivik R.T., Zarcone V., Dement W.C., Hollister L.E. Delta-9-tetrahydrocannabinol and synhexl effects on human sleep patterns. Clin Pharmacol Ther. 13:1972;426-435.
23. Porcella A., Casellas P., Gessa G.L., Pani L. Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body implications for the antiglaucoma properties of marihuana. Brain Res Mol Brain Res. 58:1998;240-245.
24. th APSS Annual Meeting, Seattle, Washington. Sleep Suppl 25:A410.
25. Romero J., Berrendero F., Manzanares J., Pérez A., Cochero J., Fuentes J.A., Fernández-Ruiz J.J., Ramos J.A. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta-9 tethahydrocannabinol. Synapse. 30:1998;298-308.
26. Tominaga K., Shinohara K., Otori Y., Fukuhara C., Inouye S.T. Circadian rhythms of vasopressin content in the suprachiasmatic nucleus of the rat. Neuroreport. 3:1992;809-812.
27. Torner C., Sánchez-Hurtado S., Aguilar-Roblero R. Diurnal variations of striatal D2 dopaminergic receptors and its relation with haloperidol-induced catalepsy. Biol Rhythm Res. 29:1998;538-545.
28. Zhuang S.Y., Kittler J., Grigorensko E.V., Kirby M.T., Sim L.J., Hapson R.E., Childers S.R., Deadwyler S.A. Effects of long-term exposure to delta-9-THC on expression of cannabinoid receptor (CB1) mRNA in different brain regions. Mol Brain Res. 62:1998;141-149.